AVE 33.3% 0.2¢ avecho biotechnology limited

what's next for 2012???, page-18

  1. 1,912 Posts.
    lightbulb Created with Sketch. 214
    In your defence lopez, I can't believe I'm saying this, there are a few lose ends at present. This is indicated with a number of 2010/2011 announcements having designated timetables that are yet to materialise. Having said that the very fact there is no mention of them does not mean they are dead it means they are delayed, and it should be expected that a company this big is actually spread thin. I do hope that company is littered with go getters of the Esra elk, but the hope in this instance is not in vein when you consider some of the less notable achievements that the company notched up in their 2010/11 year including chages to the ccompany constituition (indicating corporate focus) and the additions to the board. They are clearing focused on being a 2-3 billion company, perhaps not world beaters but a force to be reckoned with. And why has this happened (to put a play on a film title) - when Harry meets Esra,
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.